Meenakshie Bradley-Garcia

Ms. Meenakshie Bradley-Garcia

University of Ottawa, ON, Canada
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MSMelanie J. Sekeres
Melanie J. Sekeres
MBMeenakshie Bradley-Garcia
Meenakshie Bradley-Garcia
ACAlonso Martinez Canabal
Alonso Martinez Canabal
GWGordon Winocur
Gordon Winocur
A wide range of cognitive deficits, including memory loss associated with hippocampal dysfunction, have been widely reported in cancer survivors who received chemotherapy. Changes in both white matter and gray matter volume have been observed following chemotherapy treatment, with reduced volume in the medial temporal lobe thought to be due in part to reductions in hippocampal neurogenesis. Pre-clinical rodent models confirm that common chemotherapeutic agents used to treat various forms of non-CNS cancers reduce rates of hippocampal neurogenesis and impair performance on hippocampally-mediated learning and memory tasks. We review the pre-clinical rodent literature to identify how various chemotherapeutic drugs affect hippocampal neurogenesis and induce cognitive impairment. We also review factors such as physical exercise and environmental stimulation that may protect against chemotherapy-induced neurogenic suppression and hippocampal neurotoxicity. Finally, we review pharmacological interventions that target the hippocampus and are designed to prevent or reduce the cognitive and neurotoxic side effects of chemotherapy.

6 November 2019 in Psychosomatic Medicine
Verified
Journal Article
Closed access
MSMysa Bhsc Saad
Mysa Bhsc Saad
LRLaura B. Msc Ray
Laura B. Msc Ray
MBMeenakshie Bradley-Garcia
Meenakshie Bradley-Garcia
IPIryna S. Palamarchuk
Iryna S. Palamarchuk
AGAli Gholamrezaei
Ali Gholamrezaei
RRRebecca Robillard
Rebecca Robillard
Objective: We assessed mean heart rate (HR) and HR variability (HRV) across wake, rapid eye movement (REM) sleep, and non-REM (NREM) sleep, and across varying levels of NREM sleep depth in individuals with depression and sleep complaints. Methods: Retrospective polysomnographic data were obtained for 25 individuals diagnosed as having depression (84% female; mean age = 33.8 ± 12.2 years) and 31 mentally healthy controls (58.1% female; mean age = 37.2 ± 12.4 years). All were free of psychotropic and cardiovascular medication, cardiovascular disease, and sleep-related breathing disorders. HR and time-domain HRV parameters were computed on 30-second electrocardiography segments and averaged across the night for each stage of sleep and wake. Results: Compared with the control group, the depression group had higher HR across wake, REM, and all levels of NREM depth (F(1,51) = 6.3, p = .015). Significant group by sleep stage interactions were found for HRV parameters: SD of normal-to-normal intervals (SDNN; F(2.1,107.7) = 4.4, p = .014) and root mean square differences of successive R-R intervals (RMSSD; F(2.2,113.5) = 3.2, p = .041). No significant group difference was found for SDNN or RMSSD during wake (all, p ≥ .32). However, compared with the control group, the depression group had significantly lower SDNN in REM (p = .040) and all NREM stages (all p ≤ .045), and lower RMSSD during NREM 2 (p = .033) and NREM 3 (p = .034). Conclusions: This study suggests that the abnormalities in autonomic cardiac regulation associated with depression and sleep problems are more prominent during sleep, especially NREM sleep, than during wake. This may be due to abnormalities in parasympathetic modulation of cardiac activity.

29 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MBMeenakshie Bradley-Garcia
Meenakshie Bradley-Garcia
GWGordon Winocur
Gordon Winocur
MSMelanie J. Sekeres
Melanie J. Sekeres
Long-term memory disturbances are amongst the most common and disruptive cognitive symptoms experienced by breast cancer survivors following chemotherapy. To date, most clinical assessments of long-term memory dysfunction in breast cancer survivors have utilized basic verbal and visual memory tasks that do not capture the complexities of everyday event memories. Complex event memories, including episodic memory and autobiographical memory, critically rely on hippocampal processing for encoding and retrieval. Systemic chemotherapy treatments used in breast cancer commonly cause neurotoxicity within the hippocampus, thereby creating a vulnerability to memory impairment. We review structural and functional neuroimaging studies that have identified disruptions in the recollection network and related episodic memory impairments in chemotherapy-treated breast cancer survivors, and argue for the need to better characterize hippocampally mediated memory dysfunction following chemotherapy treatments. Given the importance of autobiographical memory for a person’s sense of identity, ability to plan for the future, and general functioning, under-appreciation of how this type of memory is impacted by cancer treatment can lead to overlooking or minimizing the negative experiences of breast cancer survivors, and neglecting a cognitive domain that may benefit from intervention strategies.

20 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJulie Raymond
Julie Raymond
AMAlexandre Morin
Alexandre Morin
MBMeenakshie Bradley-Garcia
Meenakshie Bradley-Garcia
HPHélène Plamondon
Hélène Plamondon
In adult rats, omega-3 supplementation through fish oil (FO) and environmental enrichment (EE) have shown beneficial effects on cognition and stress regulation. This study assessed sex-specific effects of FO and EE during adolescence, a period critical for brain maturation, on adulthood coping mechanisms, sociability, and glucocorticoid regulation. An amount of 64 Wistar rats [n = 32/sex; postnatal day (PND) 23] were assigned to supplementation of control soybean oil (CSO) or menhaden fish oil (FO; 0.3 mL/100 g) from PND28 to 47 and exposed to EE or regular cage (RC) housing from PND28 to 58, with their blood corticosterone (CORT) levels being assessed weekly. As adults, exposure to repeated forced swim tests (FSTs; PND90–91) enabled analysis of coping responses, while socioemotional and memory responses were evaluated using the OFT, EPM, SIT, and Y maze tests (PND92–94). Immunohistochemistry determined hippocampal CA1/CA3 glucocorticoid receptor (GR) expression (PND95). CORT secretion gradually increased as the supplementation period elapsed in female rats, while changes were minimal in males. Coping strategies in the FST differed between sexes, particularly in FO-fed rats, where females and males, respectively, favoured floating and tail support to minimise energy consumption and maintain immobility. In the SIT, FO/EE promoted sociability in females, while a CSO diet favoured social recognition in males. Reduced CA3 GR-ir expression was found in FO/RC and CSO/EE rat groups, supporting stress resilience and memory consolidation. Our findings support environment and dietary conditions to exert a sex-specific impact on biobehavioural responses.

1 February 2023 in The Quantitative Methods for Psychology
Verified
Journal Article
Closed access
MBMeenakshie Bradley-Garcia
Meenakshie Bradley-Garcia
VBVictoria Bolton
Victoria Bolton

14 August 2026 in Hippocampus
Verified
Journal Article
Open access
MBMeenakshie Bradley-Garcia
Meenakshie Bradley-Garcia
HKHamed Neveu Karimpour
Hamed Neveu Karimpour
DODefne Oksit
Defne Oksit
MLMitchell Lilley
Mitchell Lilley
CCChloé Cateaux
Chloé Cateaux
MSMelanie J. Sekeres
Melanie J. Sekeres
Breast cancer survivors (BCS) frequently experience chemotherapy‐related cognitive impairment, including episodic memory deficits. This study examined the long‐term impact of cancer treatment on memory for naturalistic events, using film clips to assess recall of central (gist‐like elements; reflects the story narrative) and peripheral (episodic elements; sensory or contextual details related to the event) details. While memory for both types of details typically declines over time, peripheral details are especially vulnerable to decline, and are sensitive to impairment in individuals with medial temporal lobe disruption. Participants (BCS, n = 42; noncancer controls, NC, n = 41) viewed 40 short film clips (encoding). Memory for the clips' content was tested at two timepoints: immediately following encoding (20 clips; immediate retrieval) and after a 7‐day delay (20 clips; delayed retrieval). BCS recalled significantly fewer peripheral details than NC, whereas recall of central (gist‐like) information did not differ between groups. No group differences were observed across individual sub‐categories of peripheral details, temporal sequencing, or the rate of forgetting over the 7‐day delay. Subjective memory ratings mirrored objective performance, with BCS reporting lower memory vividness than NC, while reporting comparable memory for story content. These findings suggest that chemotherapy may reduce the overall richness of episodic event representations while preserving central, schematic aspects of memory and the temporal organization of events. Naturalistic memory paradigms that assess the qualitative features of event memory may provide a sensitive approach for detecting subtle treatment‐related cognitive changes in cancer survivors.